CIK 0001790340 · <br>Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Bogle Grant C. Director | Grant or award · Stock Option | +66,700 | 66,700 | ||
| 2026-07-16 | Gengos Andrew Chief Financial Officer | Grant or award · Stock Option | +650,000 | 650,000 | ||
| 2026-06-23 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +2,400 | $4.56 | $11K | 2,315,252 |
| 2026-06-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +6,035 | $4.15 | $25K | 382,531 |
| 2026-06-11 | Schall Thomas J. Director | Grant or award · Stock Option | +33,350 | 33,350 | ||
| 2026-06-11 | HAUSMAN DIANA Director | Grant or award · Stock Option | +33,350 | 33,350 | ||
| 2026-06-11 | CARPENTER ROBERT J Director | Grant or award · Stock Option | +33,350 | 33,350 | ||
| 2026-06-11 | KEATING LAURIE Director | Grant or award · Stock Option | +33,350 | 33,350 | ||
| 2026-06-11 | Feinberg Peter Director | Grant or award · Stock Option | +33,350 | 33,350 | ||
| 2026-03-13 | Neufeld Leah R CHIEF PEOPLE OFFICER | Grant or award | +3,628 | $4.29 | $16K | 29,598 |
| 2026-02-03 | Bookman Michael CHIEF LEGAL OFFICER, SECRETARY | Grant or award · Stock Option | +176,000 | 176,000 | ||
| 2026-02-03 | Brakewood Harold Eugene Chief Business Officer | Grant or award · Stock Option | +140,000 | 140,000 | ||
| 2026-02-03 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +344,000 | 344,000 | ||
| 2026-02-03 | Matushansky Igor Chief Medical Officer | Grant or award · Stock Option | +140,000 | 140,000 | ||
| 2026-02-03 | Morales Mallory SVP Finance, CAO | Grant or award · Stock Option | +140,000 | 140,000 | ||
| 2026-02-03 | Neufeld Leah R CHIEF PEOPLE OFFICER | Grant or award · Stock Option | +140,000 | 140,000 | ||
| 2026-02-03 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +688,000 | 688,000 | ||
| 2026-01-16 | Brakewood Harold Eugene Chief Business Officer | Purchase | +5,250 | $4.76 | $25K | 11,050 |
| 2026-01-15 | Schall Thomas J. Director | Purchase | +21,645 | $4.67 | $101K | 74,530 |
| 2026-01-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Purchase | +2,298 | $4.57 | $11K | 376,496 |
Page 1 of 8 · 150 trades